{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T13:17:35Z","timestamp":1788441455291,"version":"build-2803163510"},"reference-count":42,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"the Fundamental Research Funds for the Central Universities"},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["22377060"],"award-info":[{"award-number":["22377060"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2025M772419"],"award-info":[{"award-number":["2025M772419"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the TaiShan Scholar Program of Shandong","award":["tsqn202312240"],"award-info":[{"award-number":["tsqn202312240"]}]},{"DOI":"10.13039\/501100019065","name":"Tianjin Science and Technology Plan Project","doi-asserted-by":"crossref","award":["24ZXZSSS00020"],"award-info":[{"award-number":["24ZXZSSS00020"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Drug Delivery"],"published-print":{"date-parts":[[2026,12,31]]},"DOI":"10.1080\/10717544.2026.2726824","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:46:36Z","timestamp":1788439596000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Synergistic epigenetic modulation and ferroptosis induction via codelivery of Decitabine and Sorafenib for potent anti-tumor therapy"],"prefix":"10.1080","volume":"33","author":[{"given":"Yujie","family":"Xing","sequence":"first","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]},{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Shandong Provincial University Industry-Academia-Research Collaborative and Innovation Center of Intelligent Rehabilitation Drug R&D, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Medicine, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Sun","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]},{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Shandong Provincial University Industry-Academia-Research Collaborative and Innovation Center of Intelligent Rehabilitation Drug R&D, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Medicine, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yu","sequence":"additional","affiliation":[{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Shandong Provincial University Industry-Academia-Research Collaborative and Innovation Center of Intelligent Rehabilitation Drug R&D, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Medicine, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences","place":["Jinan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Key Laboratory of Molecular Drug Research and KLMDASR of Tianjin, Nankai University","place":["Tianjin, China"]},{"name":"Qingdao Central Hospital, NHC Key Laboratory of Cardiopulmonary Rehabilitation and Functional Recovery, Shandong Provincial University Industry-Academia-Research Collaborative and Innovation Center of Intelligent Rehabilitation Drug R&D, Qingdao Key Laboratory of Precision Drug Research for Chronic Disease Rehabilitation, School of Medicine, University of Health and Rehabilitation Sciences","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201901695","article-title":"Bismuth-Based nanomaterials: recent advances in tumor targeting and synergistic cancer therapy techniques","volume":"9","author":"Badrigilan S","year":"2020","unstructured":"Badrigilan S , Choupani J , Khanbabaei H , et al. 2020. Bismuth-Based nanomaterials: recent advances in tumor targeting and synergistic cancer therapy techniques. Adv Healthc Mater. 9.","journal-title":"Adv Healthc Mater"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103211"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2021.111833"},{"key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12943-021-01346-2","article-title":"Delivery of cancer therapies by synthetic and bio-inspired nanovectors","volume":"20","author":"Briolay T","year":"2021","unstructured":"Briolay T , Petithomme T , Fouet M , et al. 2021. Delivery of cancer therapies by synthetic and bio-inspired nanovectors. Mol Cancer. 20:55.","journal-title":"Mol Cancer"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-020-00462-0"},{"key":"e_1_3_4_7_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107328","article-title":"Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy","volume":"207","author":"Chen T","year":"2024","unstructured":"Chen T , Mahdadi S , Vidal M , et al. 2024. Non-nucleoside inhibitors of DNMT1 and DNMT3 for targeted cancer therapy. Pharmacol Res. 207.","journal-title":"Pharmacol Res"},{"key":"e_1_3_4_8_1","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-020-01643-6","article-title":"The application of histone deacetylases inhibitors in glioblastoma","volume":"39","author":"Chen R","year":"2020","unstructured":"Chen R , Zhang MX , Zhou YM , et al. 2020. The application of histone deacetylases inhibitors in glioblastoma. J Exp Clin Canc Res. 39.","journal-title":"J Exp Clin Canc Res"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1205699"},{"key":"e_1_3_4_10_1","article-title":"Ferroptosis and the tumor microenvironment","volume":"43","author":"Cui KS","year":"2024","unstructured":"Cui KS , Wang K , Huang ZH . 2024. Ferroptosis and the tumor microenvironment. J Exp Clin Canc Res. 43.","journal-title":"J Exp Clin Canc Res"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.4c01253"},{"key":"e_1_3_4_12_1","article-title":"Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy","volume":"7","author":"Gao WT","year":"2022","unstructured":"Gao WT , Wang XY , Zhou Y , et al. 2022. Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy. Signal Transduct Tar. 7.","journal-title":"Signal Transduct Tar"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2015.03.033"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI99032"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2015.10.023"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2016.1164919"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c03352"},{"key":"e_1_3_4_18_1","article-title":"DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma","volume":"23","author":"Liu YF","year":"2024","unstructured":"Liu YF , Sun Y , Yang J , et al. 2024. DNMT1-targeting remodeling global DNA hypomethylation for enhanced tumor suppression and circumvented toxicity in oral squamous cell carcinoma. Mol Cancer. 23.","journal-title":"Mol Cancer"},{"key":"e_1_3_4_19_1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao4680","article-title":"Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma","volume":"10","author":"Lochmann TL","year":"2018","unstructured":"Lochmann TL , Powell KM , Ham J et al. 2018. Targeted inhibition of histone H3K27 demethylation is effective in high-risk neuroblastoma. Sci Transl Med. 10.","journal-title":"Sci Transl Med"},{"key":"e_1_3_4_20_1","doi-asserted-by":"crossref","DOI":"10.1002\/smtd.202402058","article-title":"Exosome-based theranostic for gastrointestinal cancer: advances in biomarker discovery and therapeutic engineering","author":"Mehta MJ","year":"2025","unstructured":"Mehta MJ , Shin D , Park HS , et al. 2025. Exosome-based theranostic for gastrointestinal cancer: advances in biomarker discovery and therapeutic engineering. Small Methods. e2402058.","journal-title":"Small Methods."},{"key":"e_1_3_4_21_1","article-title":"Ferroptosis, a new form of cell death: opportunities and challenges in cancer","volume":"12","author":"Mou YH","year":"2019","unstructured":"Mou YH , Wang J , Wu JC , et al. 2019. Ferroptosis, a new form of cell death: opportunities and challenges in cancer. J Hematol Oncol. 12.","journal-title":"J Hematol Oncol"},{"key":"e_1_3_4_22_1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.canlet.2014.08.010","article-title":"Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors","volume":"354","author":"Nie J","year":"2014","unstructured":"Nie J , Liu L , Li X , et al. 2014. Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors. Cancer Lett. 354:12\u201320.","journal-title":"Cancer Lett"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioactmat.2020.08.023"},{"key":"e_1_3_4_24_1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/s43018-021-00249-x","article-title":"Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia","volume":"2","author":"Pappalardi MB","year":"2021","unstructured":"Pappalardi MB , Keenan K , Cockerill M et al. 2021. Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemia. Nat Cancer. 2:1002\u20131017.","journal-title":"Nat Cancer"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-12-0076"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.7150\/thno.39434"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-018-0006-z"},{"key":"e_1_3_4_28_1","first-page":"9355","article-title":"Advances","volume":"15","author":"Shao J","year":"2020","unstructured":"Shao J , Zaro J , Shen Y . 2020. Advances in exosome-based drug delivery and tumor targeting: from tissue distribution to intracellular fate. Int J Nanomed. 15:9355\u20139371.","journal-title":"Int J Nanomed"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13238-021-00846-7"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.3c13165"},{"key":"e_1_3_4_31_1","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410630","article-title":"A mitochondria-targeted biomimetic nanomedicine capable of reversing drug resistance in colorectal cancer through mitochondrial dysfunction","volume":"12","author":"Wang X","year":"2025","unstructured":"Wang X , Xu Z , Wang J , et al. 2025. A mitochondria-targeted biomimetic nanomedicine capable of reversing drug resistance in colorectal cancer through mitochondrial dysfunction. Adv Sci (Weinh). 12:e2410630.","journal-title":"Adv Sci (Weinh)"},{"key":"e_1_3_4_32_1","article-title":"Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: a systematic analysis for the GBD 2021","volume":"17","author":"Wu ZH","year":"2024","unstructured":"Wu ZH , Xia FN , Lin R . 2024. Global burden of cancer and associated risk factors in 204 countries and territories, 1980\u20132021: a systematic analysis for the GBD 2021. J Hematol Oncol. 17.","journal-title":"J Hematol Oncol"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102564"},{"key":"e_1_3_4_34_1","article-title":"Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets","volume":"8","author":"Yang J","year":"2023","unstructured":"Yang J , Xu J , Wang W , et al. 2023. Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets. Signal Transduct Tar. 8.","journal-title":"Signal Transduct Tar"},{"key":"e_1_3_4_35_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12951-024-02298-7","article-title":"Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application","volume":"22","author":"Yang Q","year":"2024","unstructured":"Yang Q , Li S , Ou H , et al. 2024. Exosome-based delivery strategies for tumor therapy: an update on modification, loading, and clinical application. J Nanobiotechnol. 22:41.","journal-title":"J Nanobiotechnol"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2019.04.004"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12070680"},{"key":"e_1_3_4_38_1","article-title":"A multifunctional Fe-EGCG@RSL3 nanomedicine synergizes ferroptosis induction and tumor microenvironment remodeling for enhanced bladder cancer immunotherapy","volume":"8","author":"Zhang CJY","year":"2025","unstructured":"Zhang CJY , Liu S , Zhang JH et al. 2025. A multifunctional Fe-EGCG@RSL3 nanomedicine synergizes ferroptosis induction and tumor microenvironment remodeling for enhanced bladder cancer immunotherapy. Res-China. 8.","journal-title":"Res-China"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-23-2796"},{"key":"e_1_3_4_40_1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12951-022-01472-z","article-title":"Recent advances in exosome-mediated nucleic acid delivery for cancer therapy","volume":"20","author":"Zhang Y","year":"2022","unstructured":"Zhang Y , Liu Q , Zhang X , et al. 2022. Recent advances in exosome-mediated nucleic acid delivery for cancer therapy. J Nanobiotechnol. 20:279.","journal-title":"J Nanobiotechnol"},{"key":"e_1_3_4_41_1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jconrel.2022.12.026","article-title":"Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia","volume":"353","author":"Zheng X","year":"2023","unstructured":"Zheng X , Sun K , Liu Y , et al. 2023. Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia. J Control Release. 353:675\u2013684.","journal-title":"J Control Release"},{"key":"e_1_3_4_42_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2025.108649","article-title":"Epigenetic reprogramming holds promise in enhancing anti-tumor efficacy of CAR T cell therapy","volume":"83","author":"Zheng Y","year":"2025","unstructured":"Zheng Y , Zhu QY , Li XR , et al. 2025. Epigenetic reprogramming holds promise in enhancing anti-tumor efficacy of CAR T cell therapy. Biotechnol Adv. 83.","journal-title":"Biotechnol Adv"},{"key":"e_1_3_4_43_1","article-title":"Ultrasmall metal TPZ complexes with deep tumor penetration for enhancing radiofrequency ablation therapy and inducing antitumor immune responses","volume":"20","author":"Zhu LC","year":"2024","unstructured":"Zhu LC , Ren YQ , Dong MN , et al. 2024. Ultrasmall metal TPZ complexes with deep tumor penetration for enhancing radiofrequency ablation therapy and inducing antitumor immune responses. Small. 20.","journal-title":"Small"}],"container-title":["Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10717544.2026.2726824","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/10717544.2026.2726824","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10717544.2026.2726824","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:46:40Z","timestamp":1788439600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10717544.2026.2726824"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12,31]]}},"alternative-id":["10.1080\/10717544.2026.2726824"],"URL":"https:\/\/doi.org\/10.1080\/10717544.2026.2726824","relation":{},"ISSN":["1071-7544","1521-0464"],"issn-type":[{"value":"1071-7544","type":"print"},{"value":"1521-0464","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=idrd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-11-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-26","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2726824"}}